Treatment of chronic kidney disease-mineral bone disorder and vascular complications

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Over the last 30 years there have been improvements in our understanding of bone and vascular calcification in kidney disease patients. This has led to the development of new therapeutic strategies that allow more effective control of parathyroid hormone, less positive calcium balance, improved bone remodeling, and less vascular calcification. These changes in our knowledge and available treatments will be discussed.

Original languageEnglish (US)
Pages (from-to)S2-S15
JournalTherapeutic Apheresis and Dialysis
Volume10
Issue numberSUPPL. 1
DOIs
StatePublished - Dec 1 2006

Fingerprint

Chronic Kidney Disease-Mineral and Bone Disorder
Vascular Calcification
Blood Vessels
Bone Remodeling
Kidney Diseases
Parathyroid Hormone
Calcium
Bone and Bones
Therapeutics

Keywords

  • Bone
  • Calcimimetics
  • Kidney
  • Renal osteodystrophy
  • Sevelamer
  • Vascular calcification

ASJC Scopus subject areas

  • Hematology
  • Nephrology

Cite this

Treatment of chronic kidney disease-mineral bone disorder and vascular complications. / Moe, Sharon M.

In: Therapeutic Apheresis and Dialysis, Vol. 10, No. SUPPL. 1, 01.12.2006, p. S2-S15.

Research output: Contribution to journalArticle

@article{3bde748b85644ddfa3d2a2bef0a2270b,
title = "Treatment of chronic kidney disease-mineral bone disorder and vascular complications",
abstract = "Over the last 30 years there have been improvements in our understanding of bone and vascular calcification in kidney disease patients. This has led to the development of new therapeutic strategies that allow more effective control of parathyroid hormone, less positive calcium balance, improved bone remodeling, and less vascular calcification. These changes in our knowledge and available treatments will be discussed.",
keywords = "Bone, Calcimimetics, Kidney, Renal osteodystrophy, Sevelamer, Vascular calcification",
author = "Moe, {Sharon M.}",
year = "2006",
month = "12",
day = "1",
doi = "10.1111/j.1744-9987.2006.00434.x",
language = "English (US)",
volume = "10",
pages = "S2--S15",
journal = "Therapeutic Apheresis and Dialysis",
issn = "1744-9979",
publisher = "Wiley-Blackwell",
number = "SUPPL. 1",

}

TY - JOUR

T1 - Treatment of chronic kidney disease-mineral bone disorder and vascular complications

AU - Moe, Sharon M.

PY - 2006/12/1

Y1 - 2006/12/1

N2 - Over the last 30 years there have been improvements in our understanding of bone and vascular calcification in kidney disease patients. This has led to the development of new therapeutic strategies that allow more effective control of parathyroid hormone, less positive calcium balance, improved bone remodeling, and less vascular calcification. These changes in our knowledge and available treatments will be discussed.

AB - Over the last 30 years there have been improvements in our understanding of bone and vascular calcification in kidney disease patients. This has led to the development of new therapeutic strategies that allow more effective control of parathyroid hormone, less positive calcium balance, improved bone remodeling, and less vascular calcification. These changes in our knowledge and available treatments will be discussed.

KW - Bone

KW - Calcimimetics

KW - Kidney

KW - Renal osteodystrophy

KW - Sevelamer

KW - Vascular calcification

UR - http://www.scopus.com/inward/record.url?scp=33845634353&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845634353&partnerID=8YFLogxK

U2 - 10.1111/j.1744-9987.2006.00434.x

DO - 10.1111/j.1744-9987.2006.00434.x

M3 - Article

AN - SCOPUS:33845634353

VL - 10

SP - S2-S15

JO - Therapeutic Apheresis and Dialysis

JF - Therapeutic Apheresis and Dialysis

SN - 1744-9979

IS - SUPPL. 1

ER -